View Older Stories

Jun 2, 2026 04:04AM Abivax (ABVX) PT Raised to $187 at Citizens

Jun 2, 2026 01:03AM Jefferies Downgrades Abivax (ABVX) to Hold

Jun 1, 2026 04:37PM After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP

Jun 1, 2026 04:03PM Abivax (ABVX) Halted, News Pending

May 26, 2026 04:40AM Abivax (ABVX) Reiterated at Market Outperform by Citizens on Open-label Results

Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 1, 2026 04:06PM Abivax files annual reports with French and US regulators

Mar 24, 2026 10:45AM Abivax (ABVX) remains 'Best Idea' at Guggenheim following FY25 update

Mar 24, 2026 09:01AM Truist on Abivax (ABVX): 'We continue to see a robust opportunity'

Mar 24, 2026 04:09AM Abivax (ABVX) Reiterated at Market Outperform by Citizens Ahead of ABTECT-UC Results

Mar 22, 2026 10:00AM Jefferies says these are the best SMID-cap biotech stocks to buy

Mar 17, 2026 07:54AM Piper Sandler on Abivax (ABVX): 'We Remain Buyers'

Mar 16, 2026 12:58AM Jefferies Starts Abivax (ABVX) at Buy

Feb 24, 2026 06:49AM Wedbush Starts Abivax (ABVX) at Underperform

Feb 23, 2026 04:42AM Abivax (ABVX) Reiterated at Market Outperform by Citizens: Presented 22 Abstracts

Jan 13, 2026 06:07AM Guggenheim Reiterates Abivax (ABVX) at Buy, 'ABVX remains as our Best Idea'

Jan 12, 2026 09:32AM Abivax shares trim gains after French Finance Ministry statement

Jan 12, 2026 06:07AM Abivax shares surge after report flags continued Eli Lilly takeover interest

Jan 8, 2026 04:22AM Abivax (ABVX) Reiterated at Market Outperform by Citizens: Has Cash Runway into 4Q27

Jan 8, 2026 04:16AM Abivax (ABVX) PT Raised to $150 at BTIG

Jan 8, 2026 03:58AM Leerink Partners on Abivax (ABVX): 'Key Clinical & Regulatory Catalysts on Track'

Dec 22, 2025 05:33AM Abivax soars on report of Eli Lilly meeting French officials over possible deal

Dec 17, 2025 04:05PM Abivax secures 22 abstracts on inflammatory bowel disease drug at ECCO 2026

Dec 16, 2025 04:08AM Abivax (ABVX) Cash Position Supports Obefazimod Development - Citizens

Nov 24, 2025 07:34AM Truist Securities Starts Abivax (ABVX) at Buy

Nov 4, 2025 04:56AM Citizens Reiterates Abivax (ABVX) at Market Outperform After Phase 3 ABTECT Study

Oct 13, 2025 05:29AM Barclays Starts Abivax (ABVX) at Overweight

Oct 10, 2025 06:08AM Abivax (ABVX) PT Raised to $150 at Guggenheim, named 'Best Idea'

Oct 7, 2025 04:06AM Abivax (ABVX) PT Raised to $115 at Leerink Partners

Oct 6, 2025 04:55AM Abivax presents ulcerative colitis drug data at gastroenterology meeting

Oct 6, 2025 04:03AM Citizens Reiterates Market Outperform Rating on Abivax (ABVX)

Sep 25, 2025 05:03AM Abivax (ABVX) PT Raised to $114 at Citizens JMP

Sep 23, 2025 04:19AM Citizens JMP Reiterates Market Outperform Rating on Rapport Therapeutics (RAPP)

Sep 23, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Sep 15, 2025 12:52PM Guggenheim on Abivax (ABVX): 'We expect ABVX to get a late-breaker and/or a plenary session at the UEGW'

Jul 29, 2025 08:27AM Abivax (ABVX) PT Raised to $112 as Piper Sandler 'Continues to See Upside'

Jul 23, 2025 04:17PM Abivax launches $400 million public offering of American depositary shares

Jul 23, 2025 11:23AM Abivax (ABVX) PT Raised as Piper Sandler 'Remain Buyers'

Jul 23, 2025 08:29AM Morgan Stanley Upgrades Abivax (ABVX) to Overweight

Jul 23, 2025 07:54AM Abivax (ABVX) PT Raised to $74 at Leerink Partners

Jul 23, 2025 06:03AM Abivax (ABVX) PT Raised to $101 at Guggenheim

Jul 23, 2025 04:06AM Abivax (ABVX) PT Raised to $95 at Citizens JMP

Jul 18, 2025 04:29AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Jul 14, 2025 05:20AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Jul 2, 2025 09:42AM Piper Sandler Sees an 'Attractive Risk/Reward' on Abivax (ABVX) Shares

Apr 30, 2025 04:34AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Apr 22, 2025 04:00PM Abivax (ABVX) Appoints Dominik Höchli to its Board

Mar 25, 2025 09:56AM Guggenheim Reiterates Buy Rating on Abivax (ABVX), PT $50

Mar 25, 2025 04:36AM BTIG Reiterates Buy Rating on Abivax (ABVX)

Mar 20, 2025 03:21AM Morgan Stanley Assumes Abivax (ABVX) at Equalweight

View Older Stories